Tag: Subject Experts Committee
Bharat Biotech gets a nod from DGCI for phase 3 trials...
Bharat Biotech gets SEC approval for phase 3 clinical trials of nasal vaccine as a booster shot
As India stares at the third wave of...
Covaxin gets a nod for emergency use for 12-18 age group...
Covaxin gets emergency use approval for children aged between 12-18 years
As Omicron cases surges in India, the Hyderabad-based vaccine manufacturer Bharat Biotech's Covaxin on...
